Katherine Stueland, President and CEO of GeneDx, discusses developing genomic testing as a means for preventative medical treatment rather than solely an indicator of risk.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.

Bloomberg Businessweek Weekend: May 8th, 2026
38:41

Inside the AI Revival of the Infamous Three Mile Island Nuclear Plant
44:32

The Intersection of Human Psychology with AI
08:21